Skip to main content
SpringerLink
Log in

What’s new in pharmacokinetics of antimicrobials in AKI and RRT?

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813–818

    Article  CAS  PubMed  Google Scholar 

  2. Jamal JA, Udy AA, Wallis SC, Ranganathan D, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2015) Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin? Int J Artif Organs 38:419–424

    Article  CAS  PubMed  Google Scholar 

  3. Jamal JA, Udy AA, Lipman J, Roberts JA (2014) The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens. Crit Care Med 42(7):1640–1650

    Article  PubMed  Google Scholar 

  4. Roberts DM, Liu X, Roberts JA, Nair P, Cole L, Roberts MS, Lipman J, Bellomo R, RENAL Replacement Therapy Study Investigators (2015) A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care 19:84

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638

    Article  PubMed  Google Scholar 

  6. Muhl E, Martens T, Iven H, Rob P, Bruch HP (2000) Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole. Eur J Clin Pharmacol 56:671–678

    Article  CAS  PubMed  Google Scholar 

  7. Karaiskos I, Friberg LE, Galani L, Ioannidis K, Katsouda E, Athanassa Z, Paskalis H, Giamarellou H (2016) Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration. Int J Antimicrob Agents 48:337–341

    Article  CAS  PubMed  Google Scholar 

  8. Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Lefrant JY, Roberts JA (2016) Influence of renal replacement modalities on amikacin population pharmacokinetics in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother 60:4901–4909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Roger C, Wallis SC, Louart B, Lefrant JY, Lipman J, Muller L, Roberts JA (2016) Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients. J Antimicrob Chemother 71:1643–1650

    Article  CAS  PubMed  Google Scholar 

  10. Roger C, Muller L, Wallis SC, Louart B, Saissi G, Lipman J, Lefrant JY, Roberts JA (2016) Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration. J Antimicrob Chemother 71:464–470

    Article  CAS  PubMed  Google Scholar 

  11. Ulldemolins M, Soy D, Llaurado-Serra M, Vaquer S, Castro P, Rodriguez AH, Pontes C, Calvo G, Torres A, Martin-Loeches I (2015) Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements. Antimicrob Agents Chemother 59:5520–5528

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, Fissell WH (2016) Pharmacokinetics and pharmacodynamics of extended infusion versus short infusion piperacillin-tazobactam in critically ill patients undergoing CRRT. Clin J Am Soc Nephrol 11:1377–1383

    Article  PubMed  Google Scholar 

  13. Jamal JA, Mat-Nor MB, Mohamad-Nor FS, Udy AA, Wallis SC, Lipman J, Roberts JA (2015) Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents 45:41–45

    Article  CAS  PubMed  Google Scholar 

  14. Jamal JA, Roberts DM, Udy AA, Mat-Nor MB, Mohamad-Nor FS, Wallis SC, Lipman J, Roberts JA (2015) Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents 46:39–44

    Article  CAS  PubMed  Google Scholar 

  15. Brasseur A, Hites M, Roisin S, Cotton F, Vincent JL, De Backer D, Jacobs F, Taccone FS (2016) A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study. J Antimicrob Chemother 71:1386–1394

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

J.A.R. received salary funding from the National Health and Medical Research Council of Australia; Practitioner Fellowship (APP1117065). We wish to acknowledge funding from the Australian National Health and Medical Research Council for a Centre of Research Excellence (APP1099452) and a Project Grant (APP1044941).

Author information

Authors and Affiliations

  1. Department of Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Australia

    Jason A. Roberts & Jeffrey Lipman

  2. Burns, Trauma & Critical Care Research Centre, Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women’s Hospital, Butterfield St, Herston, Queensland, 4006, Australia

    Jason A. Roberts & Jeffrey Lipman

  3. Pharmacy Department, Royal Brisbane and Women’s Hospital, Brisbane, Australia

    Jason A. Roberts

  4. Centre of Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia

    Jason A. Roberts

  5. Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France

    Jean-Yves Lefrant

  6. Faculté de Médecine de Montpellier-Nimes, Université de Montpellier, Equipe d’Accueil 2992, Montpellier, France

    Jean-Yves Lefrant

Authors
  1. Jason A. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Yves Lefrant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey Lipman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason A. Roberts.

Ethics declarations

Conflicts of interest

The authors have no known conflicts of interest relating to this work. J.A.R. declares unrelated consultancies for bioMerieux, MSD, Astellas and Infectopharm over the last 3 years. J.L. and J.Y.L. declare no potential conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roberts, J.A., Lefrant, JY. & Lipman, J. What’s new in pharmacokinetics of antimicrobials in AKI and RRT?. Intensive Care Med 43, 904–906 (2017). https://doi.org/10.1007/s00134-017-4789-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-017-4789-x

Keywords

Search

Navigation